ALENTIS THERAPEUTICS TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND BIO INTERNATIONAL CONVENTION Post published:May 31, 2023 Continue ReadingALENTIS THERAPEUTICS TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND BIO INTERNATIONAL CONVENTION
ALENTIS THERAPEUTICS AWARDED CHF 2.4M SWISS ACCELERATOR GRANT BY INNOSUISSE Post published:May 9, 2023 Continue ReadingALENTIS THERAPEUTICS AWARDED CHF 2.4M SWISS ACCELERATOR GRANT BY INNOSUISSE